Macrogenics (MGNX) Current Assets (2012 - 2026)
Macrogenics (MGNX) reported Current Assets of $182.5 million for Q1 2026, little changed year-over-year from $182.1 million in Q1 2025, and down 17.01% quarter-over-quarter from $219.9 million in Q4 2025.
Macrogenics (MGNX) Current Assets (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Current Assets data on file, last reported at $182.5 million in Q1 2026.
- Current Assets for Q1 2026 came in at $182.5 million, changed 0.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $182.5 million (changed 0.24% YoY), and the FY2025 annual result was $219.9 million, up 1.13% from the prior year.
- Current Assets declined to $182.5 million in Q1 2026 per MGNX's latest filing, from $219.9 million in the prior quarter.
- Over five years, Current Assets peaked at $291.3 million in Q3 2023 and troughed at $147.8 million in Q3 2022.
- A 5-year average of $215.5 million and a median of $218.2 million in 2022 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets plunged 55.84% in 2022, then soared 97.09% in 2023.
- A 5-year view of Current Assets shows it stood at $222.2 million in 2022, then increased by 13.12% to $251.3 million in 2023, then retreated by 13.47% to $217.5 million in 2024, then increased by 1.13% to $219.9 million in 2025, then decreased by 17.01% to $182.5 million in 2026.
- Business Quant data shows MGNX's Current Assets at $182.5 million in Q1 2026, $219.9 million in Q4 2025, and $232.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 182.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 182.52 Mn |
| Dec 31, 2025 | 219.94 Mn |
| Sep 30, 2025 | 232.09 Mn |
| Jun 30, 2025 | 204.95 Mn |
| Mar 31, 2025 | 182.09 Mn |
| Dec 31, 2024 | 217.49 Mn |
| Sep 30, 2024 | 222.20 Mn |
| Jun 30, 2024 | 156.95 Mn |
| Mar 31, 2024 | 202.58 Mn |
| Dec 31, 2023 | 251.34 Mn |
| Sep 30, 2023 | 291.32 Mn |
| Jun 30, 2023 | 254.68 Mn |
| Mar 31, 2023 | 288.94 Mn |
| Dec 31, 2022 | 222.18 Mn |
| Sep 30, 2022 | 147.81 Mn |
| Jun 30, 2022 | 167.63 Mn |
| Mar 31, 2022 | 218.20 Mn |
| Dec 31, 2021 | 279.56 Mn |
| Sep 30, 2021 | 334.70 Mn |
| Jun 30, 2021 | 367.00 Mn |